Genmab — Juni 2017
-
...men dara kommer "pretty close"
-
og så rå-sælger han dara i lungecancer
-
lungcancer med dara+tecentric kommer potentially next year - if not earlier
-
Roche kan åbenbaart ikke få armene ned - men sikkert først 2018
-
haha - the "C"-word betyder noget andet her...
-
ok - det var chronic og ikke cure...
-
fik han ikke også lige sagt, at smoldering fase II kommer med forrygende data?
-
men han vil ikke byde på, hvornår vi ser data i smoldering
-
SC på markedet 2020
-
vil gå til 70-80% af markedet immediately aftermarket launch
-
patent life from late 2020's til mid 2030's
-
TF-adc really smells good - data på ESMO i Madrid
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind